Skip to main content
Top
Published in: Thrombosis Journal 1/2024

Open Access 01-12-2024 | Phlebothrombosis | Research

The genetic causal relationship between type 2 diabetes, glycemic traits and venous thromboembolism, deep vein thrombosis, pulmonary embolism: a two-sample Mendelian randomization study

Authors: Mingyi Yang, Xianjie Wan, Yani Su, Ke Xu, Pengfei Wen, Binfei Zhang, Lin Liu, Zhi Yang, Peng Xu

Published in: Thrombosis Journal | Issue 1/2024

Login to get access

Abstract

Objective

To investigate the genetic underpinnings of the association between type 2 diabetes (T2D), glycemic indicators such as fasting glucose (FG), fasting insulin (FI), and glycated hemoglobin (GH), and venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), thereby contributing novel insights to the scholarly discourse within this domain.

Methods

Genome-wide association study (GWAS) summary data pertaining to exposures (T2D, FG, FI, GH) and outcomes (VTE, DVT, PE) were acquired from the IEU Open GWAS database, encompassing participants of European descent, including both male and female individuals. Two-sample Mendelian randomization (MR) analyses were conducted utilizing the TwoSampleMR and MRPRESSO packages within the R programming environment. The primary analytical approach employed was the random-effects inverse variance weighted (IVW) method. Heterogeneity was assessed via Cochran’s Q statistic for MR-IVW and Rucker’s Q statistic for MR-Egger. Horizontal pleiotropy was evaluated using the intercept test of MR Egger and MR pleiotropy residual sum and outlier (MR-PRESSO) analysis, with the latter also employed for outlier detection. Additionally, a “Leave one out” analysis was conducted to ascertain the influence of individual single nucleotide polymorphisms (SNPs) on MR results.

Results

The random-effects IVW analysis revealed a negative genetic causal association between T2D) and VTE (P = 0.008, Odds Ratio [OR] 95% confidence interval [CI] = 0.896 [0.827–0.972]), as well as between FG and VTE (P = 0.002, OR 95% CI = 0.655 [0.503–0.853]), GH and VTE (P = 0.010, OR 95% CI = 0.604 [0.412–0.884]), and GH and DVT (P = 0.002, OR 95% CI = 0.413 [0.235–0.725]). Conversely, the random-effects IVW analysis did not detect a genetic causal relationship between FI and VTE (P > 0.05), nor between T2D, FG, or FI and DVT (P > 0.05), or between T2D, FG, FI, or GH and PE (P > 0.05). Both the Cochran’s Q statistic for MR-IVW and Rucker’s Q statistic for MR-Egger indicated no significant heterogeneity (P > 0.05). Moreover, the intercept tests of MR Egger and MR-PRESSO suggested the absence of horizontal pleiotropy (P > 0.05). MR-PRESSO analysis identified no outliers, while the “Leave one out” analysis underscored that the MR analysis was not influenced by any single SNP.

Conclusion

Our investigation revealed that T2D, FG, and GH exhibit negative genetic causal relationships with VTE at the genetic level, while GH demonstrates a negative genetic causal relationship with DVT at the genetic level. These findings furnish genetic-level evidence warranting further examination of VTE, DVT, and PE, thereby making a contribution to the advancement of related research domains.
Appendix
Available only for authorised users
Literature
2.
go back to reference Di Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet (London England). 2016;388(10063):3060–73.PubMedCrossRef Di Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet (London England). 2016;388(10063):3060–73.PubMedCrossRef
3.
go back to reference Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ. Pulmonary embolism: update on diagnosis and management. Med J Aust. 2019;211(2):82–7.PubMedCrossRef Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ. Pulmonary embolism: update on diagnosis and management. Med J Aust. 2019;211(2):82–7.PubMedCrossRef
4.
5.
go back to reference Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost. 2008;34(8):747–61.PubMedCrossRef Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost. 2008;34(8):747–61.PubMedCrossRef
6.
go back to reference Zoller B, Svensson PJ, Dahlback B, Lind-Hallden C, Hallden C, Elf J. Genetic risk factors for venous thromboembolism. Expert Rev Hematol. 2020;13(9):971–81.PubMedCrossRef Zoller B, Svensson PJ, Dahlback B, Lind-Hallden C, Hallden C, Elf J. Genetic risk factors for venous thromboembolism. Expert Rev Hematol. 2020;13(9):971–81.PubMedCrossRef
7.
go back to reference Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545–608.PubMedCrossRef Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545–608.PubMedCrossRef
8.
go back to reference Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet (London England). 2021;398(10294):64–77.PubMedCrossRef Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet (London England). 2021;398(10294):64–77.PubMedCrossRef
9.
go back to reference Majima T, Oshima Y. Venous thromboembolism in major orthopedic surgery. J Nippon Med Sch. 2021;88(4):268–72.PubMedCrossRef Majima T, Oshima Y. Venous thromboembolism in major orthopedic surgery. J Nippon Med Sch. 2021;88(4):268–72.PubMedCrossRef
10.
go back to reference Bartlett MA, Mauck KF, Stephenson CR, Ganesh R, Daniels PR. Perioperative Venous Thromboembolism Prophylaxis. Mayo Clin Proc. 2020;95(12):2775-98. Bartlett MA, Mauck KF, Stephenson CR, Ganesh R, Daniels PR. Perioperative Venous Thromboembolism Prophylaxis. Mayo Clin Proc. 2020;95(12):2775-98.
11.
go back to reference Lieberman JR, Bell JA. Venous thromboembolic Prophylaxis after total hip and knee arthroplasty. J Bone Joint Surg Am. 2021;103(16):1556–64.PubMedCrossRef Lieberman JR, Bell JA. Venous thromboembolic Prophylaxis after total hip and knee arthroplasty. J Bone Joint Surg Am. 2021;103(16):1556–64.PubMedCrossRef
12.
go back to reference Saleh J, El-Othmani MM, Saleh KJ. Deep vein thrombosis and pulmonary embolism considerations in orthopedic surgery. Orthop Clin North Am. 2017;48(2):127–35.PubMedCrossRef Saleh J, El-Othmani MM, Saleh KJ. Deep vein thrombosis and pulmonary embolism considerations in orthopedic surgery. Orthop Clin North Am. 2017;48(2):127–35.PubMedCrossRef
13.
go back to reference Morel O, Jesel L, Abbas M, Morel N. Prothrombotic changes in diabetes mellitus. Semin Thromb Hemost. 2013;39(5):477–88.PubMedCrossRef Morel O, Jesel L, Abbas M, Morel N. Prothrombotic changes in diabetes mellitus. Semin Thromb Hemost. 2013;39(5):477–88.PubMedCrossRef
14.
go back to reference Ahmadizar F, Wang K, Aribas E, Fani L, Heshmatollah A, Ikram MK, et al. Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study. BMJ Open Diabetes Res Care. 2021;9(1):e002406.PubMedPubMedCentralCrossRef Ahmadizar F, Wang K, Aribas E, Fani L, Heshmatollah A, Ikram MK, et al. Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study. BMJ Open Diabetes Res Care. 2021;9(1):e002406.PubMedPubMedCentralCrossRef
16.
go back to reference Kim HJ, Kim SM, Lee G, Choi S, Son JS, Oh YH, et al. Association between visit-to-visit fasting glycemic variability and depression: a retrospective cohort study in a representative Korean population without diabetes. Sci Rep. 2022;12(1):18692.PubMedPubMedCentralCrossRef Kim HJ, Kim SM, Lee G, Choi S, Son JS, Oh YH, et al. Association between visit-to-visit fasting glycemic variability and depression: a retrospective cohort study in a representative Korean population without diabetes. Sci Rep. 2022;12(1):18692.PubMedPubMedCentralCrossRef
17.
go back to reference Van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Bakker SJ, Kluin-Nelemans HC, Meijer K, et al. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost. 2012;10(6):1012–8.PubMedCrossRef Van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Bakker SJ, Kluin-Nelemans HC, Meijer K, et al. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost. 2012;10(6):1012–8.PubMedCrossRef
18.
go back to reference Khaw KT, Wareham N. Glycated hemoglobin as a marker of cardiovascular risk. Curr Opin Lipidol. 2006;17(6):637–43.PubMedCrossRef Khaw KT, Wareham N. Glycated hemoglobin as a marker of cardiovascular risk. Curr Opin Lipidol. 2006;17(6):637–43.PubMedCrossRef
19.
go back to reference Saito S, Teshima Y, Fukui A, Kondo H, Nishio S, Nakagawa M, et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 2014;104(1):5–14.PubMedCrossRef Saito S, Teshima Y, Fukui A, Kondo H, Nishio S, Nakagawa M, et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 2014;104(1):5–14.PubMedCrossRef
20.
go back to reference Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, et al. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017;185:140–9.PubMedCrossRef Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, et al. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017;185:140–9.PubMedCrossRef
21.
go back to reference Lin CC, Chen CC, Li CI, Liu CS, Lin WY, Lin CH, et al. Derivation and validation of a clinical prediction model for risks of venous thromboembolism in diabetic and general populations. Med (Baltim). 2021;100(39):e27367.CrossRef Lin CC, Chen CC, Li CI, Liu CS, Lin WY, Lin CH, et al. Derivation and validation of a clinical prediction model for risks of venous thromboembolism in diabetic and general populations. Med (Baltim). 2021;100(39):e27367.CrossRef
22.
go back to reference Soo Hoo GW. Overview and assessment of risk factors for pulmonary embolism. Expert Rev Respir Med. 2013;7(2):171–91.PubMedCrossRef Soo Hoo GW. Overview and assessment of risk factors for pulmonary embolism. Expert Rev Respir Med. 2013;7(2):171–91.PubMedCrossRef
23.
go back to reference Xiong X, Li T, Cheng B. Association between glycosylated hemoglobin, diabetes mellitus, and preoperative deep vein thrombosis in patients undergoing total joint arthroplasty: a retrospective study. J Orthop Surg Res. 2022;17(1):430.PubMedPubMedCentralCrossRef Xiong X, Li T, Cheng B. Association between glycosylated hemoglobin, diabetes mellitus, and preoperative deep vein thrombosis in patients undergoing total joint arthroplasty: a retrospective study. J Orthop Surg Res. 2022;17(1):430.PubMedPubMedCentralCrossRef
24.
go back to reference Zhang Y, Wang J, Zheng M, Qu H, Yang S, Han F, et al. Causal association between telomere length and colorectal polyps: a bidirectional two-sample mendelian randomization study. Medicine. 2024;103(1):e36867.PubMedPubMedCentralCrossRef Zhang Y, Wang J, Zheng M, Qu H, Yang S, Han F, et al. Causal association between telomere length and colorectal polyps: a bidirectional two-sample mendelian randomization study. Medicine. 2024;103(1):e36867.PubMedPubMedCentralCrossRef
25.
go back to reference Gu P, Pu B, Ma Y, Yue D, Xin Q, Li H, et al. Appraising the causal relationship between thyroid function and rheumatoid arthritis: a two-sample bidirectional mendelian randomization study. Front Immunol. 2023;14:1238757.PubMedPubMedCentralCrossRef Gu P, Pu B, Ma Y, Yue D, Xin Q, Li H, et al. Appraising the causal relationship between thyroid function and rheumatoid arthritis: a two-sample bidirectional mendelian randomization study. Front Immunol. 2023;14:1238757.PubMedPubMedCentralCrossRef
26.
go back to reference Cui K, Song N, Fan Y, Zeng L, Shi P, Wang Z, et al. A two-sample mendelian randomization analysis: causal association between chemokines and pan-carcinoma. Front Genet. 2023;14:1285274.PubMedPubMedCentralCrossRef Cui K, Song N, Fan Y, Zeng L, Shi P, Wang Z, et al. A two-sample mendelian randomization analysis: causal association between chemokines and pan-carcinoma. Front Genet. 2023;14:1285274.PubMedPubMedCentralCrossRef
27.
go back to reference He J, Jiang Q, Yao Y, Shen Y, Li J, Yang J, et al. Blood cells and venous thromboembolism risk: a two-sample mendelian randomization study. Front Cardiovasc Med. 2022;9:919640.PubMedPubMedCentralCrossRef He J, Jiang Q, Yao Y, Shen Y, Li J, Yang J, et al. Blood cells and venous thromboembolism risk: a two-sample mendelian randomization study. Front Cardiovasc Med. 2022;9:919640.PubMedPubMedCentralCrossRef
28.
go back to reference Lindstrom S, Germain M, Crous-Bou M, Smith EN, Morange PE, van Hylckama Vlieg A, et al. Assessing the causal relationship between obesity and venous thromboembolism through a mendelian randomization study. Hum Genet. 2017;136(7):897–902.PubMedPubMedCentralCrossRef Lindstrom S, Germain M, Crous-Bou M, Smith EN, Morange PE, van Hylckama Vlieg A, et al. Assessing the causal relationship between obesity and venous thromboembolism through a mendelian randomization study. Hum Genet. 2017;136(7):897–902.PubMedPubMedCentralCrossRef
29.
go back to reference Klovaite J, Nordestgaard BG, Tybjærg-Hansen A, Benn M. Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis. Am J Respir Crit Care Med. 2013;187(3):286–93.PubMedCrossRef Klovaite J, Nordestgaard BG, Tybjærg-Hansen A, Benn M. Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis. Am J Respir Crit Care Med. 2013;187(3):286–93.PubMedCrossRef
30.
go back to reference Wang X, Fang X, Zheng W, Zhou J, Song Z, Xu M, et al. Genetic support of a causal relationship between Iron Status and Type 2 diabetes: a mendelian randomization study. J Clin Endocrinol Metab. 2021;106(11):e4641–51.PubMedPubMedCentralCrossRef Wang X, Fang X, Zheng W, Zhou J, Song Z, Xu M, et al. Genetic support of a causal relationship between Iron Status and Type 2 diabetes: a mendelian randomization study. J Clin Endocrinol Metab. 2021;106(11):e4641–51.PubMedPubMedCentralCrossRef
31.
go back to reference Georgakis MK, Harshfield EL, Malik R, Franceschini N, Langenberg C, Wareham NJ, et al. Diabetes Mellitus, glycemic traits, and Cerebrovascular Disease: a mendelian randomization study. Neurology. 2021;96(13):e1732–42.PubMedPubMedCentralCrossRef Georgakis MK, Harshfield EL, Malik R, Franceschini N, Langenberg C, Wareham NJ, et al. Diabetes Mellitus, glycemic traits, and Cerebrovascular Disease: a mendelian randomization study. Neurology. 2021;96(13):e1732–42.PubMedPubMedCentralCrossRef
32.
go back to reference Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.CrossRef Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.CrossRef
33.
go back to reference Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc. 2010;5(9):1564–73.PubMedPubMedCentralCrossRef Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc. 2010;5(9):1564–73.PubMedPubMedCentralCrossRef
34.
go back to reference Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods. 2013;10(1):5–6.PubMedCrossRef Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods. 2013;10(1):5–6.PubMedCrossRef
35.
go back to reference Schork NJ, Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide Association studies. PLoS Genet. 2009;5(6):e1000529.CrossRef Schork NJ, Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide Association studies. PLoS Genet. 2009;5(6):e1000529.CrossRef
36.
go back to reference Bonas-Guarch S, Guindo-Martinez M, Miguel-Escalada I, Grarup N, Sebastian D, Rodriguez-Fos E, et al. Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes. Nat Commun. 2018;9(1):321.PubMedPubMedCentralCrossRef Bonas-Guarch S, Guindo-Martinez M, Miguel-Escalada I, Grarup N, Sebastian D, Rodriguez-Fos E, et al. Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes. Nat Commun. 2018;9(1):321.PubMedPubMedCentralCrossRef
37.
go back to reference Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012;8(8):e1002793.PubMedPubMedCentralCrossRef Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012;8(8):e1002793.PubMedPubMedCentralCrossRef
38.
go back to reference Chen J, Spracklen CN, Marenne G, Varshney A, Corbin LJ, Luan J, et al. The trans-ancestral genomic architecture of glycemic traits. Nat Genet. 2021;53(6):840–60.PubMedPubMedCentralCrossRef Chen J, Spracklen CN, Marenne G, Varshney A, Corbin LJ, Luan J, et al. The trans-ancestral genomic architecture of glycemic traits. Nat Genet. 2021;53(6):840–60.PubMedPubMedCentralCrossRef
39.
go back to reference Chen Y, Shen J, Wu Y, Ni M, Deng Y, Sun X, et al. Tea consumption and risk of lower respiratory tract infections: a two–sample mendelian randomization study. Eur J Nutr. 2023;62(1):385–93.PubMedCrossRef Chen Y, Shen J, Wu Y, Ni M, Deng Y, Sun X, et al. Tea consumption and risk of lower respiratory tract infections: a two–sample mendelian randomization study. Eur J Nutr. 2023;62(1):385–93.PubMedCrossRef
40.
go back to reference Xu Q, Ni JJ, Han BX, Yan SS, Wei XT, Feng GJ, et al. Causal relationship between Gut Microbiota and Autoimmune diseases: a two-sample mendelian randomization study. Front Immunol. 2021;12:746998.PubMedCrossRef Xu Q, Ni JJ, Han BX, Yan SS, Wei XT, Feng GJ, et al. Causal relationship between Gut Microbiota and Autoimmune diseases: a two-sample mendelian randomization study. Front Immunol. 2021;12:746998.PubMedCrossRef
41.
go back to reference Ni JJ, Xu Q, Yan SS, Han BX, Zhang H, Wei XT, et al. Gut Microbiota and Psychiatric disorders: a two-sample mendelian randomization study. Front Microbiol. 2021;12:737197.PubMedCrossRef Ni JJ, Xu Q, Yan SS, Han BX, Zhang H, Wei XT, et al. Gut Microbiota and Psychiatric disorders: a two-sample mendelian randomization study. Front Microbiol. 2021;12:737197.PubMedCrossRef
42.
go back to reference Shu MJ, Li JR, Zhu YC, Shen H. Migraine and ischemic stroke: a mendelian randomization study. Neurol Ther. 2022;11(1):237–46.PubMedCrossRef Shu MJ, Li JR, Zhu YC, Shen H. Migraine and ischemic stroke: a mendelian randomization study. Neurol Ther. 2022;11(1):237–46.PubMedCrossRef
43.
go back to reference Hoo GWS. Overview and assessment of risk factors for pulmonary embolism. Expert Rev Respir Med. 2013;7(2):171–91.CrossRef Hoo GWS. Overview and assessment of risk factors for pulmonary embolism. Expert Rev Respir Med. 2013;7(2):171–91.CrossRef
44.
go back to reference Anderson FA Jr., Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9–16.PubMed Anderson FA Jr., Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9–16.PubMed
45.
go back to reference Cao Z, Wu Y, Li Q, Li Y, Wu J. A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample mendelian randomization analysis. Ann Med. 2022;54(1):1636–45.PubMedPubMedCentralCrossRef Cao Z, Wu Y, Li Q, Li Y, Wu J. A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample mendelian randomization analysis. Ann Med. 2022;54(1):1636–45.PubMedPubMedCentralCrossRef
46.
go back to reference Lee YH. Causal association between smoking behavior and the decreased risk of osteoarthritis: a mendelian randomization. Z Rheumatol. 2019;78(5):461–6.PubMedCrossRef Lee YH. Causal association between smoking behavior and the decreased risk of osteoarthritis: a mendelian randomization. Z Rheumatol. 2019;78(5):461–6.PubMedCrossRef
47.
go back to reference Zhang Y, Zhao M, Guo P, Wang Y, Liu L, Zhao J, et al. Mendelian randomisation highlights hypothyroidism as a causal determinant of idiopathic pulmonary fibrosis. EBioMedicine. 2021;73:103669.PubMedPubMedCentralCrossRef Zhang Y, Zhao M, Guo P, Wang Y, Liu L, Zhao J, et al. Mendelian randomisation highlights hypothyroidism as a causal determinant of idiopathic pulmonary fibrosis. EBioMedicine. 2021;73:103669.PubMedPubMedCentralCrossRef
48.
go back to reference Wang JJ, Zhuang ZH, Shao CL, Yu CQ, Wang WY, Zhang K, et al. Assessment of causal association between thyroid function and lipid metabolism: a mendelian randomization study. Chin Med J (Engl). 2021;134(9):1064–9.PubMedCrossRef Wang JJ, Zhuang ZH, Shao CL, Yu CQ, Wang WY, Zhang K, et al. Assessment of causal association between thyroid function and lipid metabolism: a mendelian randomization study. Chin Med J (Engl). 2021;134(9):1064–9.PubMedCrossRef
49.
go back to reference Yeung CHC, Schooling CM. Systemic inflammatory regulators and risk of Alzheimer’s disease: a bidirectional mendelian-randomization study. Int J Epidemiol. 2021;50(3):829–40.PubMedCrossRef Yeung CHC, Schooling CM. Systemic inflammatory regulators and risk of Alzheimer’s disease: a bidirectional mendelian-randomization study. Int J Epidemiol. 2021;50(3):829–40.PubMedCrossRef
50.
go back to reference Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.PubMedPubMedCentralCrossRef Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.PubMedPubMedCentralCrossRef
51.
go back to reference Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.PubMedPubMedCentralCrossRef Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.PubMedPubMedCentralCrossRef
52.
go back to reference Meng H, Jiang L, Song Z, Wang F. Causal associations of circulating lipids with osteoarthritis: a bidirectional mendelian randomization study. Nutrients. 2022;14(7):1327.PubMedPubMedCentralCrossRef Meng H, Jiang L, Song Z, Wang F. Causal associations of circulating lipids with osteoarthritis: a bidirectional mendelian randomization study. Nutrients. 2022;14(7):1327.PubMedPubMedCentralCrossRef
53.
go back to reference Wang R, Liu R, Zhao L, Xu D, Hu L. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients. Rev Esp Enferm Dig. 2017;109(7):503–9.PubMed Wang R, Liu R, Zhao L, Xu D, Hu L. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients. Rev Esp Enferm Dig. 2017;109(7):503–9.PubMed
54.
go back to reference Sveinsdottir SV, Svensson PJ, Engstrom G. Inflammatory plasma markers and risk for venous thromboembolism. J Thromb Thrombolysis. 2014;38(2):190–5.PubMedCrossRef Sveinsdottir SV, Svensson PJ, Engstrom G. Inflammatory plasma markers and risk for venous thromboembolism. J Thromb Thrombolysis. 2014;38(2):190–5.PubMedCrossRef
55.
go back to reference Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost. 2015;114(4):812–8.PubMedCrossRef Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost. 2015;114(4):812–8.PubMedCrossRef
56.
go back to reference Stegenga ME, van der Crabben SN, Blumer RM, Levi M, Meijers JC, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008;112(1):82–9.PubMedPubMedCentralCrossRef Stegenga ME, van der Crabben SN, Blumer RM, Levi M, Meijers JC, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008;112(1):82–9.PubMedPubMedCentralCrossRef
57.
go back to reference Di Minno MN, Tufano A, Guida A, Di Capua M, De Gregorio AM, Cerbone AM, et al. Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res. 2011;127(3):193–7.PubMedCrossRef Di Minno MN, Tufano A, Guida A, Di Capua M, De Gregorio AM, Cerbone AM, et al. Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res. 2011;127(3):193–7.PubMedCrossRef
58.
go back to reference SH RC, Meier C, Jick SS, Meier CR, Becker C. Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study. Cardiovasc Diabetol. 2022;21(1):2.CrossRef SH RC, Meier C, Jick SS, Meier CR, Becker C. Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study. Cardiovasc Diabetol. 2022;21(1):2.CrossRef
59.
go back to reference Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15–37.PubMedCrossRef Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15–37.PubMedCrossRef
60.
go back to reference Laakso M. Insulin resistance and its impact on the approach to therapy of type 2 diabetes. Int J Clin Pract Suppl. 2001;121:8–12. Laakso M. Insulin resistance and its impact on the approach to therapy of type 2 diabetes. Int J Clin Pract Suppl. 2001;121:8–12.
61.
go back to reference Padilla J, Manrique-Acevedo C, Martinez-Lemus LA. New insights into mechanisms of endothelial insulin resistance in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2022;323(6):H1231–8.PubMedPubMedCentralCrossRef Padilla J, Manrique-Acevedo C, Martinez-Lemus LA. New insights into mechanisms of endothelial insulin resistance in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2022;323(6):H1231–8.PubMedPubMedCentralCrossRef
62.
go back to reference Choi JW, Lee MH, Fujii T. Insulin Resistance and Microalbuminuria in patients with impaired fasting glucose versus hemoglobin A1c-Defined prediabetes. Ann Clin Lab Sci. 2022;52(5):802–10.PubMed Choi JW, Lee MH, Fujii T. Insulin Resistance and Microalbuminuria in patients with impaired fasting glucose versus hemoglobin A1c-Defined prediabetes. Ann Clin Lab Sci. 2022;52(5):802–10.PubMed
63.
go back to reference Muniyappa R, Quon MJ. Insulin action and insulin resistance in vascular endothelium. Curr Opin Clin Nutr Metab Care. 2007;10(4):523–30.PubMedCrossRef Muniyappa R, Quon MJ. Insulin action and insulin resistance in vascular endothelium. Curr Opin Clin Nutr Metab Care. 2007;10(4):523–30.PubMedCrossRef
64.
65.
go back to reference Fonseca VA. The effects of insulin on the endothelium. Endocrinol Metab Clin North Am. 2007;36(Suppl 2):20–6.PubMedCrossRef Fonseca VA. The effects of insulin on the endothelium. Endocrinol Metab Clin North Am. 2007;36(Suppl 2):20–6.PubMedCrossRef
66.
go back to reference Salobir B, Sabovic M. A metabolic syndrome independent association between overweight, fibrinolysis impairment and low-grade inflammation in young women with venous thromboembolism. Blood Coagul Fibrinolysis. 2006;17(7):551–6.PubMedCrossRef Salobir B, Sabovic M. A metabolic syndrome independent association between overweight, fibrinolysis impairment and low-grade inflammation in young women with venous thromboembolism. Blood Coagul Fibrinolysis. 2006;17(7):551–6.PubMedCrossRef
67.
go back to reference Jensen TB, Gerds TA, Grøn R, Bretler DM, Schmiegelow MD, Andersson C, et al. Risk factors for venous thromboembolism during pregnancy. Pharmacoepidemiol Drug Saf. 2013;22(12):1283–91.PubMedCrossRef Jensen TB, Gerds TA, Grøn R, Bretler DM, Schmiegelow MD, Andersson C, et al. Risk factors for venous thromboembolism during pregnancy. Pharmacoepidemiol Drug Saf. 2013;22(12):1283–91.PubMedCrossRef
68.
go back to reference Jiao X, Li Z, An S, Huang J, Feng M, Cao G. Does diabetes mellitus increase the incidence of early thrombosis in deep vein following unicompartmental knee arthroplasty: a retrospective cohort study. BMC Geriatr. 2022;22(1):448.PubMedPubMedCentralCrossRef Jiao X, Li Z, An S, Huang J, Feng M, Cao G. Does diabetes mellitus increase the incidence of early thrombosis in deep vein following unicompartmental knee arthroplasty: a retrospective cohort study. BMC Geriatr. 2022;22(1):448.PubMedPubMedCentralCrossRef
69.
go back to reference Jeraj L, Spirkoska A, Ježovnik MK, Poredoš P. Deep vein thrombosis and properties of the arterial wall. Vasa. 2018;47(3):197–201.PubMedCrossRef Jeraj L, Spirkoska A, Ježovnik MK, Poredoš P. Deep vein thrombosis and properties of the arterial wall. Vasa. 2018;47(3):197–201.PubMedCrossRef
70.
go back to reference Zhou Z, Zhou H, Zou X, Wang X, Yan M. Formononetin regulates endothelial nitric oxide synthase to protect vascular endothelium in deep vein thrombosis rats. Int J Immunopathol Pharmacol. 2022;36:3946320221111117.PubMedCrossRef Zhou Z, Zhou H, Zou X, Wang X, Yan M. Formononetin regulates endothelial nitric oxide synthase to protect vascular endothelium in deep vein thrombosis rats. Int J Immunopathol Pharmacol. 2022;36:3946320221111117.PubMedCrossRef
71.
go back to reference Castellana G, Intiglietta P, Dragonieri S, Carratù P, Buonamico P, Peragine M, et al. Incidence of deep venous thrombosis in patients with both pulmonary embolism and COPD. Acta Biomed. 2021;92(3):e2021210.PubMedPubMedCentral Castellana G, Intiglietta P, Dragonieri S, Carratù P, Buonamico P, Peragine M, et al. Incidence of deep venous thrombosis in patients with both pulmonary embolism and COPD. Acta Biomed. 2021;92(3):e2021210.PubMedPubMedCentral
72.
go back to reference Kang J, Jiang X, Wu B. Analysis of risk factors for lower-limb deep venous thrombosis in old patients after knee arthroplasty. Chin Med J (Engl). 2015;128(10):1358–62.PubMedCrossRef Kang J, Jiang X, Wu B. Analysis of risk factors for lower-limb deep venous thrombosis in old patients after knee arthroplasty. Chin Med J (Engl). 2015;128(10):1358–62.PubMedCrossRef
73.
go back to reference Tripodi A, Branchi A, Chantarangkul V, Clerici M, Merati G, Artoni A, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis. 2011;31(2):165–72.PubMedCrossRef Tripodi A, Branchi A, Chantarangkul V, Clerici M, Merati G, Artoni A, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis. 2011;31(2):165–72.PubMedCrossRef
74.
go back to reference Jimenez-Garcia R, Albaladejo-Vicente R, Hernandez-Barrera V, Villanueva-Orbaiz R, Carabantes-Alarcon D, de-Miguel-Diez J, et al. Type 2 diabetes is a risk factor for suffering and for in-hospital mortality with Pulmonary Embolism. A Population-based study in Spain (2016–2018). Int J Environ Res Public Health. 2020;17(22):8347.PubMedPubMedCentralCrossRef Jimenez-Garcia R, Albaladejo-Vicente R, Hernandez-Barrera V, Villanueva-Orbaiz R, Carabantes-Alarcon D, de-Miguel-Diez J, et al. Type 2 diabetes is a risk factor for suffering and for in-hospital mortality with Pulmonary Embolism. A Population-based study in Spain (2016–2018). Int J Environ Res Public Health. 2020;17(22):8347.PubMedPubMedCentralCrossRef
75.
go back to reference Rendina D, De Bonis S, Gallotta G, Piedimonte V, Mossetti G, De Filippo G, et al. Clinical, historical and diagnostic findings associated with right ventricular dysfunction in patients with central and non-massive pulmonary embolism. Intern Emerg Med. 2010;5(1):53–9.PubMedCrossRef Rendina D, De Bonis S, Gallotta G, Piedimonte V, Mossetti G, De Filippo G, et al. Clinical, historical and diagnostic findings associated with right ventricular dysfunction in patients with central and non-massive pulmonary embolism. Intern Emerg Med. 2010;5(1):53–9.PubMedCrossRef
76.
go back to reference Nikpay M, Mohammadzadeh S. Phenome-wide screening for traits causally associated with the risk of coronary artery disease. J Hum Genet. 2020;65(4):371–80.PubMedCrossRef Nikpay M, Mohammadzadeh S. Phenome-wide screening for traits causally associated with the risk of coronary artery disease. J Hum Genet. 2020;65(4):371–80.PubMedCrossRef
77.
go back to reference Adams AL, Paxton EW, Wang JQ, Johnson ES, Bayliss EA, Ferrara A, et al. Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am. 2013;95(6):481–7.PubMedCrossRef Adams AL, Paxton EW, Wang JQ, Johnson ES, Bayliss EA, Ferrara A, et al. Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am. 2013;95(6):481–7.PubMedCrossRef
78.
go back to reference Bell EJ, Selvin E, Lutsey PL, Nambi V, Cushman M, Folsom AR. Glycemia (hemoglobin A1c) and incident venous thromboembolism in the atherosclerosis risk in communities cohort study. Vasc Med. 2013;18(5):245–50.PubMedPubMedCentralCrossRef Bell EJ, Selvin E, Lutsey PL, Nambi V, Cushman M, Folsom AR. Glycemia (hemoglobin A1c) and incident venous thromboembolism in the atherosclerosis risk in communities cohort study. Vasc Med. 2013;18(5):245–50.PubMedPubMedCentralCrossRef
79.
go back to reference Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, et al. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World J Gastroenterol. 2017;23(28):5187–95.PubMedPubMedCentralCrossRef Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, et al. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World J Gastroenterol. 2017;23(28):5187–95.PubMedPubMedCentralCrossRef
80.
go back to reference Giordano NJ, Jansson PS, Young MN, Hagan KA, Kabrhel C, Epidemiology. Pathophysiology, stratification, and Natural History of Pulmonary Embolism. Tech Vasc Interv Radiol. 2017;20(3):135–40.PubMedCrossRef Giordano NJ, Jansson PS, Young MN, Hagan KA, Kabrhel C, Epidemiology. Pathophysiology, stratification, and Natural History of Pulmonary Embolism. Tech Vasc Interv Radiol. 2017;20(3):135–40.PubMedCrossRef
Metadata
Title
The genetic causal relationship between type 2 diabetes, glycemic traits and venous thromboembolism, deep vein thrombosis, pulmonary embolism: a two-sample Mendelian randomization study
Authors
Mingyi Yang
Xianjie Wan
Yani Su
Ke Xu
Pengfei Wen
Binfei Zhang
Lin Liu
Zhi Yang
Peng Xu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2024
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-024-00600-z

Other articles of this Issue 1/2024

Thrombosis Journal 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine